These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6445604)

  • 41. Effect of etofylline clofibrate on experimental thrombosis and platelet function.
    Sim AK; Davies ME; McCraw AP; Metz G
    Arzneimittelforschung; 1980; 30(11b):2042-5. PubMed ID: 7194057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface.
    Aldenhoff YB; van Der Veen FH; ter Woorst J; Habets J; Poole-Warren LA; Koole LH
    J Biomed Mater Res; 2001 Feb; 54(2):224-33. PubMed ID: 11093182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of platelet deposition on vascular grafts using an antiplatelet graft coating technique.
    Allen BT; Sparks RE; Welch MJ; Mason NS; Mathias CJ; Clark RE
    J Surg Res; 1984 Jan; 36(1):80-8. PubMed ID: 6228692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of platelets by autogenous vein grafts is not prevented by acetylsalicylic acid and dipyridamole.
    Gershlick AH; Syndercombe-Court YD; Murday AJ; Lewis CT; Mills PG
    Cardiovasc Res; 1984 Jul; 18(7):391-6. PubMed ID: 6744359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Early scanning electron microscopy changes in the surface of woven dacron vessel prosthesis. An experimental study in dogs].
    Walter P; Geroulanos S; Turina M; Senning A
    Helv Chir Acta; 1979 May; 46(1-2):81-90. PubMed ID: 157343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
    Rajah SM; Penny AF; Crow MJ; Pepper MD; Watson DA
    Br J Clin Pharmacol; 1979 Nov; 8(5):483-9. PubMed ID: 508556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts.
    DeCampli WM; Kosek JC; Mitchell RS; Handen CE; Miller DC
    Ann Surg; 1988 Dec; 208(6):746-54. PubMed ID: 3196097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
    Nunn B; James FJ
    Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?
    Goldman M; Hall C; Dykes J; Hawker RJ; McCollum CN
    Br J Surg; 1983 Oct; 70(10):635-8. PubMed ID: 6414571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
    Groves HM; Kinlough-Rathbone RL; Cazenave JP; Dejana E; Richardson M; Mustard JF
    J Lab Clin Med; 1982 Apr; 99(4):548-58. PubMed ID: 7038012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in man.
    Maguire ED; Pay GF; Turney J; Wallis RB; Weston MJ; White AM; Williams LC; Woods HF
    Haemostasis; 1981; 10(3):153-64. PubMed ID: 7262644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
    [No Abstract]   [Full Text] [Related]  

  • 53. Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft.
    Kempczinski RF; Ramalanjaona GR; Douville C; Silberstein EB
    Surgery; 1987 Apr; 101(4):439-44. PubMed ID: 3563890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of platelet inhibitory therapy on graft thromboresistance.
    Bearn PE; Bull H; Seddon AM; Marston A; McCollum CN
    Int J Exp Pathol; 1993 Oct; 74(5):425-31. PubMed ID: 8217777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

  • 57. Adverse effects of high dose aspirin on platelet adhesion to experimental autogenous vein grafts.
    Gershlick AH; Syndercombe Court YD; Murday AJ; Lewis CT; Mills PG
    Cardiovasc Res; 1985 Dec; 19(12):770-6. PubMed ID: 3910252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
    Harker LA; Hanson SR
    J Clin Invest; 1979 Aug; 64(2):559-60. PubMed ID: 110835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

  • 60. Platelet adherence to collagen. The influence of acetylsalicylic acid.
    Mant MJ
    Haemostasis; 1982; 12(3):262-7. PubMed ID: 7141304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.